Ticker Details
Lyell Immunopharma, Inc.
IPO Date:	June 17, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$354.91M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 4.31%
Avg Daily Range (30 D):	$0.69 | 4.97%
Avg Daily Range (90 D):	$0.72 | 3.85%

Institutional Daily Volume
Avg Daily Volume:	.05M
Avg Daily Volume (30 D):	.15M
Avg Daily Volume (90 D):	.09M

Trade Size
Avg Trade Size (Sh.):	10
Avg Trade Size (Sh.) (30 D):	48
Avg Trade Size (Sh.) (90 D):	44

Institutional Trades
Total Institutional Trades:	354
Avg Institutional Trade:	$1.98M
Avg Institutional Trade (30 D):	$2.9M
Avg Institutional Trade (90 D):	$2.4M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.33M
Avg Closing Trade (30 D):	$3.89M
Avg Closing Trade (90 D):	$3.35M
Avg Closing Volume:	34.95K

News

Jun 12, 2026 @ 4:45 PM Lyell Immunopharma Presents Updated Safety Data an... Source: Na

Jun 8, 2026 @ 10:00 AM Lyell Immunopharma Provides Update on Safety Profi... Source: Na

Mar 9, 2026 @ 12:00 PM Lyell Immunopharma Announces Closing of Additional... Source: Na

Dec 9, 2025 @ 1:00 PM Century Therapeutics Appoints Accomplished Biotech... Source: Century Therapeutics

Dec 7, 2025 @ 9:30 PM Lyell Immunopharma Presents New Clinical Data from... Source: Lyell Immunopharma

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-13.8	$-1.1	$-7.68
Diluted EPS	$-13.8	$-1.1	$-7.68
Revenue	$.03M	$M	$.01M
Gross Profit
Net Income / Loss	$-246.41M	$-24.15M	$-140.72M
Operating Income / Loss	$-256.3M	$-44.26M	$-127.64M
Cost of Revenue
Net Cash Flow	$-29.66M	$30.59M	$-63.39M
PE Ratio

Splits
Jun 02, 2025	1:20